The FDA said risks linked to CAR-T cell therapies can be effectively communicated through existing labeling, including boxed ...

Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to ...

A new medication found to reduce the chance of the most common types of breast cancer recurring will be available to many ...

For the first time in Australia, a drug that can delay the growth of tumours is available under the Pharmaceutical Benefits ...

Datroway (datopotamab deruxtecan) is the first TROP2-directed therapy approved for advanced lung cancer in the U.S.

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...

Pfizer insists that the discontinuation of the Phase II study was due to recruitment difficulties and was not linked to ...

A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

Despite recent ASCO and FDA guidance recommending the inclusion of people living with HIV in pivotal cancer trials, nearly 75 ...